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ABSTRACT 
Objectives The evidence for an association between depression and anxiety and increased 
hypertension risk is inconsistent. We aimed to investigate the association between each of 
depression and anxiety and incident hypertension.  
Methods We included women born 1946-51 from the Australian Longitudinal Study on 
Women’s Health, surveyed triennially from 1998-2013, without a history of hypertension at 
baseline. We defined depression using the CESD-10 scale and anxiety using self-reported 
doctor-diagnosis. We related depression and anxiety to incident hypertension, using 
generalised estimating equations, adjusting for time-varying covariates. 
Results Among 9182 women, 2738 developed hypertension during 15 years follow-up. 
Depression was associated with a 30% increased odds of hypertension (age-adjusted OR 
1.30, 95% CI 1.19 to 1.43). This attenuated and was no longer significant in fully adjusted 
analyses (1.07, 95% CI 0.96 to 1.20). Adjusting for BMI alone reduced the association 
markedly (OR 1.19, 95% CI 1.08 to 1.31). Anxiety was similarly associated with increased 
odds of hypertension, but this association became non-significant after adjusting for 
depression (OR 1.12, 95% CI 0.97 to 1.30).  
Conclusions The frequently observed association between depression and hypertension may 
be explained by confounding, whilst co-morbid depression may account for the apparent 
effect of anxiety on hypertension risk. However, further research is needed to determine 
whether factors such as BMI play a mediating role on a causal pathway between depression 
and hypertension. Nevertheless, weight and weight gain among women with depression 
should be closely monitored to reduce potential effects on hypertension risk.  
Key words: hypertension; depression; anxiety; women; BMI  
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INTRODUCTION 
Cardiovascular and cerebrovascular disease (CVD) are the leading cause of mortality 
worldwide, whilst poor mental health is a major cause of morbidity. The Global Burden of 
Disease Study reported that mental and substance use disorders are the leading global cause 
of all non-fatal burden of disease, as measured by years lived with disability [1]. Depressive 
disorders contributed most to this burden of disease, followed by anxiety disorders [1]. 
Common mental disorders such as depression and anxiety appear to disproportionately 
affect women [2], whilst CVD outcomes are often  poorer in women than men [3]. 
Furthermore, there is growing evidence that depression and anxiety are associated with 
increased risk of CVD [4, 5]. However, this complex relationship is far from understood and it 
remains unclear whether depression and anxiety are actually causally related to the 
development of CVD, with alternative potential explanations for the observed association 
yet to be disproved. On the other hand, plausible pathophysiologic mechanisms that may 
well underlie this association have been proposed. This includes the potential for 
psychological factors, such as depression and anxiety, to increase the risk of arterial 
hypertension, a major risk factor for CVD [6]. However, the observational evidence to 
support this is conflicting. Among the few prospective studies that have addressed this 
question, some found no association between depression and hypertension [7, 8], whereas 
others found depression to be associated with an increased [9, 10] or decreased risk of 
hypertension [11, 12]. Despite substantial heterogeneity between the methodology and 
results of existing prospective studies, a recent systematic review of these cohort studies 
concluded that depression is ‘probably an independent risk factor for hypertension’, but 
recommended that further studies are needed to exclude the role of a wider range of 
confounding factors [13]. The evidence for an association between anxiety and hypertension 
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risk is more convincing, although substantial cross-study heterogeneity in the magnitude of 
effect does exist [14]. Importantly, to date, most prospective studies of the association 
between depression and anxiety and hypertension collected information on exposures and 
confounders at baseline only, with very few having collected repeated measurements over 
time [15, 16].  
Given the inconsistencies in the existing literature and shortcomings of existing studies, we 
sought to investigate whether depression and anxiety are associated with incident 
hypertension using data from the Australian Longitudinal Study on Women’s Health 
(ALSWH).  
METHODS 
Study setting and population 
We included participants from the ALSWH, a national population-based study of women 
born in 1921-26, 1946-51 and 1973-78.  Women were randomly selected from the Medicare 
database, which covers all citizens and permanent residents of Australia, including refugees 
and immigrants. We included women from the 1946-51 cohort who were surveyed using 
self-administered questionnaires in 1996 (survey 1 [S1], N=13,715), 1998 (survey 2 [S2], 
N=12,338 [90% response rate]), and every three years thereafter until 2013 (survey 7 [S7], 
N= 9151). Full details of recruitment and response rates for all surveys are reported 
elsewhere [17, 18]. For the purposes of this study we included women from the 1946-51 
cohort who did not report ever having a history of doctor-diagnosed hypertension at S2, 
thereby identifying a ‘hypertension-free’ cohort of women. We did not identify this cohort of 
women from S1 because information on depressive symptoms was collected from S2 
onwards.  
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In accordance with the Declaration of Helsinki, ethical approval for the ALSWH was obtained 
from the Universities of Newcastle and Queensland Research Ethics Committees and all 
participants gave informed consent to be included in the study. 
Hypertension 
At each survey subsequent to S2, women were asked “In the past three years have you been 
diagnosed with or treated for hypertension?” (i.e. since the previous survey), to which they 
could respond “yes” or “no”. We defined incident hypertension as first reported occurrence 
of hypertension during the entire follow-up period, with women who reached this end-point 
not contributing to analysis thereafter.  
Depression and anxiety 
Depressive symptoms experienced in the last week were identified using the Center for 
Epidemiological Studies Depression scale shortened version (CESD-10) [19], which is well-
validated and has good test-retest reliability and predictive validity compared with the 
original 20-item format [19-21]. In primary analyses we defined depression at each time 
point as being present if women scored ≥10 on the CESD-10 scale. 
Women were also asked at S2 if they had been diagnosed with or treated for anxiety in 
either “the past two years” (i.e. since S1) or “ever”. In subsequent surveys women were 
asked about the diagnosis of or treatment for anxiety in the previous three years (i.e. since 
the last survey). 
Covariates 
Lifestyle, physiological and disease history variables were determined at each survey. 
Smoking was classified as never, ex-smoker or current smoker. Body mass index (kg/m2) was 
computed as self-reported weight (kg)/height (m2), and in descriptive tables presented as a 
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continuous and also a categorical variable using the following categories (underweight 
[<18.5 kg/m2], normal weight [18.5-24.9 kg/m2], overweight [25-29.9 kg/m2] or obese [≥ 30 
kg/m2]). BMI was treated as a continuous variable in the regression models. At S2, physical 
activity was assessed using a modified (self-report) version of the Active Australia Physical 
Activity Survey [22, 23]. The women were asked to report frequency and total duration of 
walking, moderate, and vigorous intensity leisure time physical activity during the last week. 
A physical activity score in metabolic equivalent (MET) minutes per week was derived using 
the following formula:  MET min/week = (walking minutes * 3.5 METs) + (moderate minutes 
* 4.0 METs) + (vigorous minutes * 7.5 METs). Physical activity was categorized as sedentary 
(0-39 MET min/week), low (40-599 MET min/week), moderate (600-1199 MET min/week) 
and high (≥ 1200 MET min/week). Alcohol intake was defined in light of the Australian 
National Health and Medical Research Council (NHMRC) guidelines with ‘Risky drinkers’ (15 
to 28 drinks per week) and ‘High risk drinkers’ (more than 28 drinks per week) categorised 
accordingly [24]. Given the low frequency of high risk drinkers, the latter two groups were 
combined. For women identified as low risk by the NHMRC guidelines, we separately 
categorised women who reported that they drink only rarely (any alcohol consumption less 
than once a month) and non-drinkers, with the remainder classified as low-risk drinkers (up 
to 14 drinks per week). 
Socioeconomic status (SES) was determined by two measures. Education level, collected at 
S1 only, was classified as high (university degree or diploma), middle (trade/apprenticeship 
or high school qualification(s)) or low (no formal qualifications). At all surveys women were 
also asked how well they managed on their income and could respond ‘easy’, ‘not bad’, 
‘difficult sometimes’, ‘difficult all of the time’ or ‘impossible’. We grouped this variable into 
three categories of: easy/not bad; difficult sometimes; and difficult all of the 
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time/impossible. Relationship status at each survey was categorised into: married/de-factor 
partner; divorced/separated/widowed; and single.  Area of residence at S2, classified as 
urban or rural/remote, was included as a covariate in the statistical modelling since women 
from rural/remote areas were deliberately over-sampled to ensure sufficient representation 
of women from these less populated areas. 
At S2, women were asked if they had ever been diagnosed with or treated for diabetes 
mellitus, heart disease or stroke.  Subsequently, they were asked if they had been diagnosed 
with these conditions in the period since the previous survey. Menopausal status at each 
survey was determined from women’s responses to questions on hysterectomy, 
oophorectomy, hormone replacement therapy use (HRT), oral contraceptive use (OCP) and 
menstrual bleeding and took into account responses at previous surveys. Menopausal status 
was defined as: pre-menopausal; surgical menopause; HRT use; OCP use; peri-menopausal; 
and post-menopausal.  
 Statistical analysis 
All analyses were performed using Stata v14.0. 
We compared baseline characteristics of women according to occurrence of incident 
hypertension during the entire follow-up period using the Pearson’s chi-squared test and 
student’s t-test. To account for multiple observations for each participant, we used 
generalised estimating equation (GEE) regression models for binary outcome data (using an 
unstructured correlation structure and a logit link function). We calculated odds ratios (ORs) 
with 95% confidence intervals (CIs) for the relationship between each of depression and 
anxiety and hypertension, including depression and anxiety as time-varying covariates. In 
our analyses women who reported hypertension did not contribute to the analyses of time 
periods thereafter. Ability to manage on income and all physiological and lifestyle variables 
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were included as time-varying covariates. Once women reported diabetes, stroke or heart 
disease, they were considered to have it at each subsequent survey. Time lags were used so 
that exposures, including depression and anxiety, were associated with stroke occurring at 
the subsequent survey. For the association between depression and hypertension, we 
calculated age-adjusted ORs before additionally adjusting for groups of covariates: anxiety; 
history of heart disease, diabetes and stroke; menopausal status; SES; marital status; all 
lifestyle factors; individual lifestyle factors; SES and all lifestyle factors; all factors. Similarly, 
for the association between anxiety and hypertension, we adjusted for the same groups of 
confounders plus depression.  
Sensitivity analyses 
Additional information related to depression was collected in the surveys. Women were 
asked at each survey whether they had ever been diagnosed with or treated for depression. 
In S2-S4 women were also asked “During the past four weeks have you taken any 
medications for depression”, and in S5 and S6 women were asked to list the medications 
they had taken in the previous four weeks.  For the latter two surveys we ascertained anti-
depressant use from the anatomical therapeutical chemical system, by identifying 
medications coded as N06A or N06B. In sensitivity analyses, we repeated the primary 
analyses using two alternative definitions of depression, to assess the impact of the 
definition of depression on the results: presence of depressive symptoms as defined by 
CESD-10 or medication for depression/anti-depressant use; and a combination of depressive 
symptoms as defined by CESD-10 or medication for depression/anti-depressant use or 
diagnosed with or treated for depression by a doctor. We also repeated our analysis after 
excluding all women who had ever reported use of medication for depression or anti-
depressant medication. 
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RESULTS 
Among 13,715 women who returned S1, 12,338 (90%) returned S2, 9966 of whom reported 
that they had never had hypertension. Follow-up data on hypertension occurrence was 
available in 9410 women, of whom 9149 women were included in the analyses, with 9024 
included in the depression analyses and 9126 in the anxiety analyses (Figure 1). The mean 
age of the 9149 women at S2 was 49.5 (±1.4 SD).  
Between 1998 and 2013, 2738 (30%) women reported having been diagnosed with 
hypertension. Incident hypertension during the follow-up period was significantly associated 
with alcohol intake, BMI, physical activity level, education level, history of diabetes, history 
of stroke and menopausal status at S2 (Table 1).  
At S2, 1950 (22.1%) women were classified as depressed, whilst 1111 (12.2%) reported 
diagnosis of or treatment for anxiety. Similar frequencies of depression and anxiety were 
observed at S3-S6. Depression at S2 was significantly associated with all included 
characteristics, apart from area of residence, whilst anxiety was associated with all 
characteristics apart from age, area of residence, alcohol intake, BMI, physical activity and 
history of diabetes mellitus (Supplementary Table 1).  
In GEE modelling, depression was associated with a 27% increased odds of incident 
hypertension (age-adjusted OR 1.27, 95% CI 1.15 to 1.40; Figure 2). Adjustment for each of: 
diabetes, heart disease or stroke; anxiety; marital status and menopausal status had little 
effect on this association, whereas adjustment for education level and ability to manage on 
income did attenuate the association (OR 1.18, 95% CI 1.06 to 1.30). Individual adjustment 
for smoking and alcohol intake did not attenuate the association, whilst adjustment for BMI, 
and to a much lesser extent, physical activity, did (adjusted ORs 1.16, 95% CI 1.04 to 1.28 
and 1.21, 95% 1.09 to 1.34, respectively; Figure 2). After adjustment for all factors, the 
11 
 
association was no longer statistically significant (OR 1.02, 95% CI 0.91 to 1.15; Figure 2). The 
results of sensitivity analyses, where we defined depression according to: depressive 
symptoms or use of anti-depressants/medication for depression; and the presence of either 
depressive symptoms, use of anti-depressants/medication for depression or doctor-
diagnosed depression gave similar associations between depression and incident 
hypertension as in the primary analysis (supplementary Tables 2 and 3). Interestingly, 
sensitivity analyses in which we excluded all women reporting any use of anti-
depressants/medicine for depression showed similar findings, albeit ORs were slightly 
attenuated compared to the primary analysis findings (supplementary Table 4).  
The association between anxiety and incident hypertension was slightly weaker than that 
observed for depression and hypertension. Anxiety was associated with a 24% increased 
odds of hypertension (age-adjusted OR 1.24, 95% CI 1.09 to 1.42; Figure 3). After adjusting 
for age and depression, this association attenuated and was no longer statistically significant 
(OR 1.15, 95% CI 0.99 to 1.32). Adjustment for all factors attenuated the OR further (OR 
1.06, 95% CI 0.90 to 1.24). 
DISCUSSION 
In our study of mid-aged women, depression and anxiety were associated with a 30% and 
24% increased odds of hypertension. However, the association for depression was markedly 
reduced after controlling for BMI and was no longer significant after full adjustment for 
confounding variables. The association between anxiety and hypertension was no longer 
significant after adjusting for depression.  
Our finding that depression is associated, in unadjusted analyses, with a 30% increased odds 
of hypertension is in keeping with the unadjusted magnitude of effect reported in previous 
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prospective studies [10, 25, 26]. However, our findings suggest that lifestyle and 
socioeconomic factors may confound this association. Findings from previous studies are 
mixed in terms of whether the association persists after adjustment for potential 
confounders. As in our study, some found no significant association between depression and 
hypertension risk after adjusting for confounding factors [7, 27-29], whilst others found a 
positive association persisted [16, 25, 26, 30, 31]. Differential associations by age have been 
observed in some studies, with a positive association observed in mid-aged adults [9, 10], 
but not in younger adults [10] or older aged adults [9]. These mixed findings are likely partly 
explained by differences in study population, age-group, gender composition, definition of 
depression, adjustment for confounders, and other methodological factors. It is possible that 
effect estimates from prospective studies that did not adjust for time-varying covariates may 
be residually confounded, particularly where participants were followed up over a long 
period of time. However, our study, and the results of previous studies, cannot exclude the 
possibility that there is indeed a true causal association between depression and 
hypertension. It is feasible that lifestyle factors, particularly BMI, may partly mediate the 
association between the two, in which case adjustment for these factors may adjust out and 
obscure any true causal association. Few studies reported on effect estimates after 
sequential adjustment for confounders, but, as in our study, Tickhonoff et al also found that 
adjustment for BMI (as well as female gender) had a large impact on the effect estimate 
[16]. Ideally, we would have performed mediation analyses in the present study to test the 
hypothesis that weight gain may partly mediate a causal association between depression 
and hypertension. However, in this mid-aged cohort, almost half of the women were already 
overweight or obese at baseline. It would therefore be more powerful to test the hypothesis 
that BMI may partially mediate the association between depression and hypertension in a 
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slightly younger cohort, where the occurrence of depression prior to weight gain can be 
more reliable ascertained. 
The lack of association between anxiety and hypertension in our study is in contrast to the 
findings from a recent meta-analysis of prospective studies [14]. Although we did find a 
positive association in unadjusted analyses, this did not persist after adjustment for 
depression (whereas the association between depression and hypertension was not affected 
by adjusting for anxiety). None of the previous studies included in the recent systematic 
review adjusted for depression in their analyses of anxiety and hypertension occurrence. 
Anxiety is known to increase the risk of developing depression [32]. Our findings suggest that 
depression, but not anxiety, is associated with increased risk of hypertension, and that the 
observed association between anxiety and hypertension in other studies may be due to the 
increased risk of depression among those with anxiety.  
Our study has a number of strengths. It is based on a large, nationally representative study 
population. The long follow-up period meant that we identified a large number of cases of 
incident hypertension, enabling us to draw conclusions about the long-term associations 
between depression and anxiety and incident hypertension. Since women were surveyed 
multiple times during follow-up we were able to measure depression occurrence repeatedly 
over time and account for changes in lifestyle and other confounding variables in our 
analyses. Finally, we used an objective measurement of depressive symptoms, and also 
performed a series of sensitivity analyses examining the effects of different definitions of 
depression. 
Limitations 
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Our study has some limitations. Anxiety, hypertension occurrence and covariates, including 
lifestyle behaviour and cardiovascular disease, were self-reported. We relied on self-report 
of doctor-diagnosed anxiety, which means that we may not have identified women with 
anxiety who have not sought medical help. Although hypertension occurrence was also 
based on self-report of doctor-diagnosis, validity studies do suggest that self-reported 
hypertension has good validity when compared to health records, with one study reporting 
that 86% of self-reported hypertension cases were verified by medical records and high 
agreement was associated with being female and aged <65 years[33]. In addition, the 
prevalence of self-reported hypertension is in line with age-specific estimates from other 
Australian health surveys [34]. Furthermore, to have impacted the key findings, 
misclassification would need to have been differential. It is possible that people with 
depression or anxiety may over-report chronic conditions such as hypertension. If so, this 
would have overestimated rather than underestimated the association with hypertension. 
Misclassification of covariates such as BMI and physical activity may have occurred. 
However, self-reported height and weight have been shown to be valid for calculating BMI in 
this cohort.[35] The physical activity questionnaire in this study has also been found to have 
measurement properties which compare favourably with those of other commonly used 
physical activity measures [36]. We were unable to adjust for the potential confounding 
effect of medication use in our analyses because the information collected on on medication 
use varied across surveys, with information on all medication use only collected in surveys 5 
and 6.  Weight gain and increased risk of hypertension are known to be side-effects of some 
anti-depressant drugs [12, 37]. However, reassuringly, our sensitivity analysis in which we 
examined the effect of depression on hypertension risk among women who did not report 
either use of medication for depression in surveys 3 and 4 or specific anti-depressant 
15 
 
medication use in surveys 5 and 6 gave very similar results to the primary analysis.Our 
measurement of depression did not measure depression status between surveys, which, 
given that depression and anxiety can be episodic and are known to fluctuate, is a limitation. 
However, sensitivity analyses using alternate measures of depression (including doctor-
diagnosed depression), gave similar findings and our study improves on cohort studies that 
measured depression and/or anxiety at one time point. Finally, our study population 
included mid-aged women and thus we cannot necessarily extrapolate our results to women 
outside this age-group or to men. 
CONCLUSIONS 
In our study of mid-aged women, depression was associated with a substantial increased risk 
of hypertension. There are a number of practical implications for the care of women with 
depression. Our findings contribute to the growing evidence for a need for improved 
prevention and monitoring of hypertension in those with depression by mental health and 
primary care practitioners. Whilst the mechanism underlying the association between 
depression and hypertension remains unclear, our findings suggest that lifestyle, in 
particular BMI, may partially confound and/or mediate the association. Practitioners are 
therefore urged to monitor BMI in those with depression, to reduce excessive weight gain, 
especially in women. Further research, ideally in a slightly younger cohort, is needed to 
determine whether BMI confounds or mediates the association between depression and 
hypertension. This would further contribute to our understanding of whether depression has 
a direct physiological impact or whether the pathway to hypertension risk is explained by 
other factors, such as BMI. Our findings that the association between anxiety and 
hypertension may be explained by confounding by depression deserves further 
investigation, to confirm or refute these findings.    
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Table 1 Characteristics at survey 2, according to whether or not women subsequently 
developed hypertension  
Characteristic 
Hypertension 
N = 2738 
n (%) 
No hypertension 
N = 6444 
n (%) P-value† 
Age (years; mean ± SD) 49.6 (± 1.4) 49.5 (± 1.5) <0.001 
Area of residence    
   Urban 934 (34.3) 2426 (37.9) 
0.005    Rural 1619 (59.5) 3624 (56.6) 
   Remote 170 (6.2) 358 (5.6) 
Marital status    
  Married/de facto 2272 (83.5) 5344 (83.4) 
0.35   Separated/divorced/widowed 373 (13.7) 847 (13.2) 
  Single 77 (2.8) 216 (3.4) 
Smoking     
  Never  1504 (57.0) 3543 (56.2) 
0.57   Ex-smoker 705 (26.7) 1634 (26.6) 
  Current 429 (16.3) 1055 (17.2) 
Alcohol intake    
  Low risk  1358 (51.5) 3462 (56.4) 
<0.001   Non /rarely 1121 (42.5) 2370 (38.6) 
  Risky/ high risk 159 (6.0) 303 (4.9) 
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BMI  (kg/m2)    
  Normal (18.5-24.9) 926 (37.0) 3313 (57.3) 
<0.001 
  Underweight (<18.5) 26 (1.0) 112 (1.9) 
  Overweight (25.0-29.9) 878 (35.1) 1694 (29.3) 
  Obese (≥30) 670 (26.8) 666 (11.5) 
BMI  (kg/m2; mean ± SD) 27.4 (± 5.4) 24.9 (± 4.4) <0.001 
Physical activity    
  High 704 (27.6) 1863 (31.1) 
0.003 
  Moderate 570 (22.3) 1370 (22.9) 
  Low 817 (32.0) 1762 (29.4) 
  Nil/ Sedentary 464 (18.2) 993 (16.6) 
Education level    
  High 814 (30.0) 2122 (33.2) 
0.002   Medium 1411 (52.0) 3287 (51.4) 
  low 491 (18.1) 988 (15.4) 
Ability to manage on income    
  Easy/not too bad 1447 (55.1) 3598 (58.9) 
0.002   Difficult some of the time 779 (29.6) 1706 (27.9) 
  Difficult/Impossible 402 (15.3) 809 (13.2) 
Type I or Type II Diabetes 
Mellitus 
  
 
   No 2671 (97.6) 6376 (98.9) <0.001 
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   Yes 67 (2.5) 68 (1.1) 
History of heart disease    
   No 2693 (98.4) 6356 (98.6) 
0.31 
   Yes 45 (1.6) 88 (1.4) 
History of stroke    
   No 2714 (99.1) 6419 (99.6) 
0.003 
   Yes 24 (0.9) 25 (0.4) 
Menopausal status    
    Premenopausal 623 (22.9) 1579 (24.6) 
<0.001 
    Surgical menopause 825 (30.3) 1445 (22.7) 
    HRT use  321 (11.8) 683 (10.7) 
    OCP use 95 (3.5) 273 (4.3) 
    Peri menopausal 582 (21.4) 1676 (26.1) 
    Post-menopausal 279 (10.2) 748 (11.7) 
†p-values of mantel-haenszel chi2 test (for dichotomous or categorical variables) or student’s 
t-test (for continuous variables) 
BMI = body mass index; HRT = hormone replacement therapy; OCP = oral contraceptive use 
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Figure Legends 
Figure 1 Flow diagram of included participants 
Figure 2 Odds ratios for the association between depression and incident hypertension, with 
individual adjustment for confounding factors 
Figure 3 Odds ratios for the association between anxiety and incident hypertension, with 
individual adjustment for confounding factors 
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Supplementary Table 1 Baseline characteristics of participants without hypertension at survey 2, according to 
depression and anxiety status at survey 2 
Characteristic 
Depression* 
N = 1864 
n (%) 
No Depression  
N = 6761 
n (%) P-value† 
Anxiety* 
(N = 1111) 
n (%) 
No anxiety 
(N = 8015) 
n (%) P-value† 
Age (years; mean ± SD) 49.4  (± 1.47) 49.5  (± 1.44) 0.02 49.5 (± 1.47) 49.5 (± 1.44) 0.67 
Area of residence       
   Urban 712 (36.1) 2426 (36.1) 
0.19 
450 (38.7) 2998 (36.6) 
0.25    Rural 1042 (56.1) 3904 (58.2) 655 (56.3) 4707 (57.5) 
   Remote 105 (5.7) 384 (5.7) 59 (5.1) 488 (6.0) 
Marital status 
      
  Married/de facto 1401 (76.0) 5759 (85.6) 
<0.001 
883 (76.4) 6906 (84.2) 
<0.001   Separated/divorced/widowed 373 (20.2) 762 (11.3) 235 (20.3) 1027 (12.5) 
  Single 70 (3.8) 211 (3.1) 38 (3.3) 265 (3.2) 
Smoking        
  Never  954 (51.7) 3884 (57.7) 
<0.001 
535 (50.1) 4512 (57.1) 
<0.001   Ex-smoker 447 (24.2) 1833 (27.2) 295 (27.7) 2083 (26.4) 
  Current 443 (24.0) 1011 (15.0) 237 (22.2) 1302 (16.5) 
Alcohol intake       
  Low risk  921 (50.2) 3801 (56.5) 
<0.001 
552 (52.1) 4341 (55.0) 
0.13   Non /rarely 807 (44.0) 2581 (38.4) 442 (41.7) 3142 (39.8) 
  Risky/ high risk 108 (5.9) 345 (5.1) 66 (6.2) 411 (5.2) 
BMI  (kg/m2)       
  Normal (18.5-24.9) 800 (46.3) 3353 (52.7) 
<0.001 
521 (51.9) 3794 (51.0) 
<0.001 
  Underweight (<18.5) 47 (2.7) 89 (1.4) 33 (3.3) 108 (1.5) 
  Overweight (25.0-29.9) 536 (31.0) 1971 (31.0) 300 (29.9) 2322 (31.2) 
  Obese (≥30) 345 (20.0) 956 (15.0) 149 (14.9) 1221 (16.4) 
BMI  (kg/m2; mean ± SD) 26.1 (± 5.3) 25.6 (± 4.7) <0.001 25.5 (± 4.9) 25.7 (± 4.8) 0.14 
Physical activity       
  High 427 (24.0) 2077 (31.6) 
<0.001 
286 (27.5) 2326 (30.3) 
0.35 
  Moderate 344 (19.3) 1556 (23.7) 243 (23.4) 1726 (22.5) 
  Low 562 (31.6) 1955 (29.8) 321 (30.9) 2322 (30.2) 
  Nil/ Sedentary 447 (25.1) 969 (14.9) 189 (18.2) 1278 (17.0) 
Education level       
  High 508 (27.5)  2274 (33.9)  
<0.001 
341 (29.4)  2639 (32.3)  
<0.001   Medium 935 (50.5) 3497 (52.1) 574 (49.5) 4248 (51.9) 
  Low 407 (22.0) 945 (14.1) 245 (21.1) 1291 (15.8) 
Ability to manage on income       
  Easy/not too bad 780 (42.2) 4162 (62.2) 
<0.001 
493 (46.2) 4627 (58.9) 
<0.001   Difficult some of the time 592 (32.1) 1817 (27.2) 332 (31.1) 2213 (28.2) 
  Difficult/Impossible 475 (25.7) 712 (10.6) 242 (22.7) 1018 (13.0) 
Type I or Type II Diabetes Mellitus       
   No 1823 (97.8) 6675 (98.7) 
0.01 
1147 (98.3) 8123 (98.5) 
0.50 
   Yes 41 (2.2) 86 (1.3) 20 (1.7) 120 (1.5) 
History of heart disease       
   No 1820 (97.6) 6683 (98.9) 
<0.001 
1138 (97.5) 8129 (98.6) 
<0.01 
   Yes 44 (2.4) 78 (1.2) 29 (2.5) 114 (1.4) 
History of stroke       
   No 1844 (98.9) 6739 (99.7) 
<0.001 
1154 (98.9) 8204 (99.5) 
<0.01 
   Yes 20 (1.1) 22 (0.3) 13 (1.1) 39 (0.5) 
History of anxiety       
   No 1365 (73.2) 6246 (92.4) <0.001 - - - 
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   Yes 499 (26.8) 515 (7.6) - - 
History of depression       
   No - - 
- 
443 (42.1) 6418 (80.8) 
<0.001 
   Yes - - 622 (57.9) 1522 (19.2) 
Menopausal status       
    Premenopausal 325 (17.5) 1752 (26.0) 
<0.001 
213 (18.3) 2029 (24.7) 
<0.001 
    Surgical menopause 609 (32.9) 1523 (22.6) 384 (33.0) 1976 (24.1) 
    HRT use  262 (14.1) 713 (10.6) 173 (14.9) 854 (10.4) 
    OCP use 49 (2.6) 316 (4.7) 29 (2.5) 340 (4.2) 
    Peri-menopausal 427 (23.0) 1682 (25.0) 271 (23.3) 2035 (24.8) 
    Post-menopausal 181 (9.8) 749 (11.1) 94 (8.1) 968 (11.5) 
*Numbers with and without each of depression and anxiety are based on women with data on these exposures at S2. Women in whom this 
information was missing at S2 but present in at least one subsequent survey were however included in the analyses. The denominators for 
depression and anxiety therefore do not equal the total number of women in included in the generalised estimating equation statistical models.   
BMI = body mass index; HRT = hormone replacement therapy; OCP = oral contraceptive use 
†p-values of the chi-square test for categorical variables and t-test for continuous variables, comparing each of depression versus no depression 
and anxiety versus no anxiety 
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Supplementary Table 2 Odds ratios for the association between depression (defined as CESD-10 
score ≥10 or use of medication for depression/antidepressant use) and hypertension incidence (N = 
9024) 
 
Adjustment Odds ratio (95% CI) p-value 
Adjusted for age only 1.30 (1.19 to 1.43) <0.001 
Adjusted for age & anxiety 1.27 (1.16 to 1.40) <0.001 
Adjusted for age & diabetes, heart disease 
& stroke 
1.27 (1.16 to 1.39) <0.001 
Adjusted for age & menopausal status 1.27 (1.16 to 1.39) <0.001 
Adjusted for age, education and manage 
on income 
1.22 (1.11 to 1.34) <0.001 
Adjusted for marital status 1.31 (1.19 to 1.43) <0.001 
Adjusted for age & all lifestyle factors 1.14 (1.03 to 1.26) <0.01 
Adjusted for age and smoking 1.30 (1.19 to 1.43) <0.001 
Adjusted for age and BMI 1.18 (1.08 to 1.30) <0.001 
Adjusted for age and physical activity 1.21 (1.09 to 1.34) <0.001 
Adjusted for age and alcohol status 1.28 (1.17 to 1.40) <0.001 
Adjusted for age, education, manage on 
income and all lifestyle factors 
1.11 (1.01 to 1.23) 0.04 
Adjusted for all factors 1.07 (0.96 to 1.19) 0.25 
 
Supplementary Table 3 Odds ratios for the association between depression (defined as CESD-10 
score ≥10, used of medication for depression/anti-depressant use, or doctor-diagnosed depression) 
and hypertension incidence (N =9151) 
 
Adjustment Odds ratio (95% CI) p-value 
Adjusted for age only 1.27 (1.16 to 1.38) <0.001 
Adjusted for age & anxiety 1.25 (1.14 to 1.37) <0.001 
Adjusted for age & diabetes, heart disease 
& stroke 
1.24 (1.13 to 1.35) <0.001 
Adjusted for age & menopausal status 1.23 (1.13 to 1.34) <0.001 
Adjusted for age, education and manage 
on income 
1.19 (1.09 to 1.30) <0.001 
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Adjusted for marital status 1.27 (1.16 to 1.38) <0.001 
Adjusted for age & all lifestyle factors 1.12 (1.02 to 1.23) 0.01 
Adjusted for age and smoking 1.26 (1.16 to 1.38) <0.001 
Adjusted for age and BMI 1.16 (1.06 to 1.27) <0.01 
Adjusted for age and physical activity 1.18 (1.07 to 1.30) <0.01 
Adjusted for age and alcohol status 1.21 (1.11 to 1.33) <0.001 
Adjusted for age, education, manage on 
income and all lifestyle factors 
1.09 (0.99 to 1.21) 0.07 
Adjusted for all factors 1.06 (0.95 to 1.18) 0.29 
 
Supplementary Table 4 Odds ratios for the association between depression (defined as CESD-10 
score ≥10) and hypertension, after excluding women reporting any anti-depressant medication use 
(N = 7304) 
 
Adjustment Odds ratio (95% CI) p-value 
Adjusted for age only 1.23 (1.08 to 1.39) <0.01 
Adjusted for age & anxiety 1.22 (1.07 to 1.39) <0.01 
Adjusted for age & diabetes, heart disease 
& stroke 
1.21 (1.06 to 1.37) <0.01 
Adjusted for age & menopausal status 1.21 (1.07 to 1.38) <0.01 
Adjusted for age, education and manage 
on income 
1.16 (1.02 to 1.31) 0.03 
Adjusted for marital status 1.23 (1.09 to 1.40) <0.01 
Adjusted for age & all lifestyle factors 1.11 (0.97 to 1.28) 0.12 
Adjusted for age and smoking 1.23 (1.09 to 1.40) <0.01 
Adjusted for age and BMI 1.14 (1.00 to 1.30) 0.05 
Adjusted for age and physical activity 1.18 (1.03 to 1.34) 0.01 
Adjusted for age and alcohol status 1.21 (1.06 to 1.37) <0.01 
Adjusted for age, education, manage on 
income and all lifestyle factors 
1.09 (0.95 to 1.26) 0.22 
Adjusted for all factors 1.07 (0.93 to 1.24) 0.33 
 
 
 
